Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies. - sprookjes - yvandenbroek - TriplyDB

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

http://www.wikidata.org/entity/Q37910273

about

Targeting Th17 Cells with Small Molecules and Small Interference RNA CD133, Selectively Targeting the Root of Cancer The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease Aptamers as theranostic agents: modifications, serum stability and functionalisation Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells.EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.

P2860

Q26770523-FC7028A7-31FC-4A60-BCD2-0535E54D6587 Q28066353-DF5DBED9-3C26-404A-B0A0-0CEEF227A641 Q28486906-CF6F4871-7553-4D60-9894-1321FAA71347 Q34698624-B27F25D7-D289-4BDA-A57E-8E01268B3F52 Q36777717-343E3278-5A07-4D73-9725-84EBD170153A Q37383122-97E4E6EE-442C-4B81-AEA5-BB87045A17BD Q37607750-3AA558C3-93A4-4E59-BCEC-BECC4874421C Q39276310-E54A0CC3-1167-49DD-B8BF-9A262EF8907D Q47735319-B94A6819-4F39-4E57-AF35-BD7296AB890E Q50656099-B2A1CBBB-5A93-4DA6-898A-B22CF5ADF259

P2860

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

http://www.wikidata.org/entity/Q37910273

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical applications of aptam ...... n haematological malignancies.

@en

Clinical applications of aptam ...... n haematological malignancies.

@nl

type

label

Clinical applications of aptam ...... n haematological malignancies.

@en

Clinical applications of aptam ...... n haematological malignancies.

@nl

prefLabel

Clinical applications of aptam ...... n haematological malignancies.

@en

Clinical applications of aptam ...... n haematological malignancies.

@nl

P1433

Q37910273-D2E80AB4-B01E-4913-95A8-685E86B4A261

P1476

Q37910273-434728E0-DFB0-4EF5-B709-CA931DF0F8F2

P2093

Q37910273-27D19D77-017B-44E3-A206-7E0B1CA382AA

Q37910273-679DFC12-FB75-4867-B703-E09CACAC6456

Q37910273-BA82591D-A4D7-4CCC-A954-61352287A3EE

Q37910273-D71DDA4F-46DA-4807-9637-9568C3E8FF8B

Q37910273-E257B183-BA44-4CC8-A671-EC6CFB436D26

P2860

Q37910273-0029DBC6-F59A-40F3-96D5-72BB9DD15E2F

Q37910273-047D5059-F9D9-46D7-BD97-66B838C3B1D3

Q37910273-0658B6B9-3C0B-41BC-B159-24D60700B254

Q37910273-14BEE4CE-4BB1-4D23-B6CD-3A95781D2C2F

Q37910273-1B627CC1-F074-4953-9D2F-E70D02EE2338

Q37910273-1EBCA003-F389-4DAC-B1BB-3942EB215CC7

Q37910273-27E2AC31-194B-4CFA-8EAB-C91C786C027A

Q37910273-299BFD05-8297-453B-9256-62C013C3A47D

Q37910273-2C795E4C-3B62-4902-81A8-4D441564055C

Q37910273-2D8FAB16-9461-453A-944D-593733635377

P304

Q37910273-64A58188-26A0-47F5-8CAB-DA9B7E5835C7

P31

Q37910273-EB4B9B30-B03E-4A4E-8FDF-6F68C693DC8D

P356

Q37910273-87975275-23DA-4789-B33F-E22AEEB5114B

P407

Q37910273-74BB2D9A-4D3F-4A97-B648-1C27B1223176

P433

Q37910273-ABA67C9C-8528-444B-BA46-D10B02DD2876

P478

Q37910273-7CF8119A-AB96-45B7-93C0-716763451FB9

P50

Q37910273-D7C12663-3D95-4901-802B-581E5EBB4602

P577

Q37910273-7121C041-32E8-422B-B75D-A8C33B59DF50

P5875

Q37910273-1F1C53CC-AD06-4DD3-B148-6E6BF437CF5E

P698

Q37910273-504CB751-65A5-4815-AC71-FE100EA51B92

P356

J.1365-2141.2011.08807.X

P1433

British Journal of Haematology

P1476

Clinical applications of aptam ...... n haematological malignancies.

@en

P2093

Abhijit De

http://www.w3.org/2001/XMLSchema#string

Chaoyong J Yang

http://www.w3.org/2001/XMLSchema#string

Mingqian Wei

http://www.w3.org/2001/XMLSchema#string

Sarah Shigdar

http://www.w3.org/2001/XMLSchema#string

Wei Duan

http://www.w3.org/2001/XMLSchema#string

P2860

The microRNA Registry

Therapeutic microRNA strategies in human cancer

The prognostic and functional role of microRNAs in acute myeloid leukemia

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

Origins and Mechanisms of miRNAs and siRNAs

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

In vitro selection of RNA molecules that bind specific ligands

Metastasis to bone: causes, consequences and therapeutic opportunities

Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia

Adaptive recognition by nucleic acid aptamers.

P304

3-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2011.08807.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

Alister C. Ward

P577

2011-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51541160

http://www.w3.org/2001/XMLSchema#string

P698

21810089

http://www.w3.org/2001/XMLSchema#string